• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. SCREW BIOSURE REGENESORB 8MM X 25MM RT; FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. SCREW BIOSURE REGENESORB 8MM X 25MM RT; FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE Back to Search Results
Model Number 72204400
Medical Device Problem Codes Break (1069); Material Separation (1562)
Health Effect - Clinical Codes No Information (3190); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/22/2020
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that during an arthroscopy the screw was turned away when the screw was turned in, it broke.The procedure was completed with a backup device and no significant delay or further complications were reported.All available information has been disclosed.If additional information should become available, a supplemental report will be submitted accordingly.
 
Additional Manufacturer Narrative
The reported device, used in treatment, was received for evaluation.There was a relationship found between the returned device and the reported incident.A visual inspection found one screw intact and the second is screw broken missing the bottom half.Based on the condition of the product material found during visual inspection it was determined that additional material testing is not required.A review of the raw materials, found that the storage requirements, material specifications, and material tests were appropriately documented.A review of the device records showed there were no indications to suggest that the product did not meet manufacturing specification or would not be able to perform as intended.A complaint history review concluded this was an isolated event.A review of risk management files found that the reported failure was documented appropriately.The instructions for use were reviewed and found to include conditions of off label use and technique specifics, as well as precautions and warnings related to the use of the device.The complaint was confirmed.Factors that could have contributed to the reported event include excessive force on the device, excessive torque on the device tip, attempted correction of a damaged device, or an inadvertent impact event.No containment or corrective actions are recommended at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SCREW BIOSURE REGENESORB 8MM X 25MM RT
Common Device Name
FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE
Manufacturer (Section D)
SMITH & NEPHEW, INC.
130 forbes blvd.
mansfield MA 02048
MDR Report Key10848119
Report Number1219602-2020-01847
Device Sequence Number3250384
Product Code MAI
UDI-Device Identifier00885554036763
UDI-Public00885554036763
Combination Product (Y/N)N
Initial Reporter CountryGM
PMA/510(K) Number
K142948
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 06/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2020
Device Model Number72204400
Device Catalogue Number72204400
Device Lot Number50737905
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/26/2020
Supplement Date Received by Manufacturer05/27/2021
Initial Report FDA Received Date11/16/2020
Supplement Report FDA Received Date06/18/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age33 YR
-
-